“The compound SR-17018 is the 1st biased agonist on the mu opioid receptor that does not result in tolerance with chronic use,” suggests Stahl, a senior staff scientist within the Bohn lab. “This is a attractive aspect for prospective use while in the context of Continual, significant soreness.” Don’t skip a eureka instant! Get the